Arisafe 250mg Injection
Marketer
Arika Healthcare
Salt Composition
Hydroxyprogesterone (250mg)
Overview Arisafe 250mg Injection
To help prevent premature births and reduce the risk of preterm delivery, pregnant women may be given Arisafe 250mg Injection. It also aids in miscarriage prevention for women with a history of premature births. Administration is strictly by or under a physician's direct supervision; dosage and duration are determined solely by your doctor. Continue using the injection for the prescribed period. Common side effects include injection site reactions, nausea, itching, diarrhea, and rash. Report any concerning side effects to your doctor; management options are available. Because this medication might impact blood sugar, regular monitoring is crucial. Immediately notify your doctor of any jaundice (yellowing of eyes or skin), dark urine, or abdominal pain. Before initiating treatment, disclose any history of circulatory problems, diabetes, liver conditions, or other medications you're currently using, as these may affect Arisafe's efficacy or mechanism of action.
Uses of Arisafe 250mg Injection
Averting Preterm Birth
Major Benefits of Arisafe 250mg Injection:
This medication will be administered by your physician or their associate; self-medication is strictly prohibited.
Common Side effects of Arisafe 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Arisafe 250mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Arisafe 250mg Injection works:
Arisafe 250mg injection contains a progestin, a type of female hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Arisafe 250mg Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Arisafe 250mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; clinical data in humans, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Arisafe, 250mg, poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, with no observed harm to infants.
DrivingSAFE
Driving ability is typically unaffected by Arisafe 250mg Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Arisafe 250mg Injection's use in individuals with renal impairment. Physician consultation is advised. The drug's progesterone content may induce fluid retention in patients with pre-existing kidney conditions.
LiverUNSAFE
The use of Arisafe 250mg Injection is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Arisafe 250mg Injection :
Omit a scheduled Arisafe 250mg Injection? Seek medical advice immediately.
Facts to Know About Arisafe 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, mineralocorticoids, and progestins |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | First-Generation Progestins |
3,018 People bought this recently